Company Valuation: Black Diamond Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 193.1 65.46 145.1 121.1 138.4 75.28 - -
Change - -66.1% 121.66% -16.54% 14.33% -45.62% - -
Enterprise Value (EV) -16.69 -57.35 145.1 121.1 138.4 75.28 75.28 75.28
Change - -243.68% 353.01% -16.54% 14.33% -45.62% 0% 0%
P/E -1.54x -0.71x -1.49x -1.69x 6.23x -1.87x -1.4x -1.42x
PBR 0.98x - - - - - - -
PEG - 0x 0.1x 0.1x -0x 0x -0x 1.26x
Capitalization / Revenue - - - - 1.98x - - -
EV / Revenue - - - - 0x - - -
EV / EBITDA 0x 0x - -0x 0x -1.56x -1.18x -0.91x
EV / EBIT 0x 0x -0x -0x 0x -1.55x -1.1x -0.8x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -3.47 -2.52 -1.88 -1.27 0.39 -0.7012 -0.9362 -0.9257
Distribution rate - - - - - - - -
Net sales 1 - - - - 70 - - -
EBITDA 1 -126.7 -92.32 - -78.44 20.2 -48.13 -64.04 -83.06
EBIT 1 -126.9 -92.83 -86.46 -78.78 19.87 -48.6 -68.45 -94.38
Net income 1 -125.6 -91.17 -82.44 -69.68 22.37 -41.16 -64.23 -90.09
Net Debt -209.8 -122.8 - - - - - -
Reference price 2 5.330 1.800 2.810 2.140 2.430 1.310 1.310 1.310
Nbr of stocks (in thousands) 36,229 36,366 51,635 56,585 56,975 57,468 - -
Announcement Date 3/17/22 A 3/9/23 A 3/12/24 A 3/6/25 A 3/16/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-1.87x - - - 75.28M
16.7x6.32x12.11x1.79% 63.66B
31.66x8.45x27.93x0.07% 58.56B
37.7x6.72x20.09x0.86% 54.19B
40.47x5.8x27.69x-.--% 44.66B
32.08x3.11x13.42x-.--% 40.51B
36.47x8.88x23.19x0.36% 36.27B
-19.34x51.61x-20.92x-.--% 34.89B
41.15x7.94x26.62x-.--% 32.26B
-87.55x16.38x-94.1x-.--% 31.01B
Average 12.75x 12.80x 4.00x 0.34% 40B
Weighted average by Cap. 18.50x 11.45x 8.40x 0.45%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Black Diamond Therapeutics, Inc.

Historical PBR trend

Valuation ratios - PBR - Black Diamond Therapeutics, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Black Diamond Therapeutics, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Black Diamond Therapeutics, Inc.

  1. Stock Market
  2. Stocks
  3. BDTX Stock
  4. Valuation Black Diamond Therapeutics, Inc.